16 research outputs found

    PHA-Induced<sup> 3</sup>H-Thymidine Stimulation and Urinary Arsenic (Inorganic + Organic) in Normal Human Blood Donors.

    No full text
    <p>Note: AsB = arseno betaine, MMA<sup>+5</sup> and DMA<sup>+5</sup> also include MMA<sup>+3</sup> and DMA<sup>+3</sup>.</p><p>PHA-Induced<sup> 3</sup>H-Thymidine Stimulation and Urinary Arsenic (Inorganic + Organic) in Normal Human Blood Donors.</p

    Arsenite Suppresses Anti-CD3/Anti-CD28 Naïve HPBMC T cell Differentiation.

    No full text
    <p>Note: DP = double positive; Values shown are the Mean ± SD with *indicating statistical significance at p<.05.</p><p>Arsenite Suppresses Anti-CD3/Anti-CD28 Naïve HPBMC T cell Differentiation.</p

    Evaluation of As<sup>+3</sup> inhibition of HPBMC proliferation.

    No full text
    <p>In panel A, the typical response of 15 donors is shown where there is no inhibition of PHA-induced T cell proliferation. In panel B, 2 donors are shown that were extremely sensitive to low dose (0.1–1 nM) inhibition of the PHA response. Data shown are the Mean ± SD with *p<.05.</p

    Correlation analysis of MMA in urine with PHA-induced T cell stimulation (<sup>3</sup>H-Thymidine counts per minute (CPM).

    No full text
    <p>There is an indication of a weak correlation between urinary MMA (combined MMA<sup>+3</sup> and MMA<sup>+5</sup>) amounts and CPM in the 13 donors analyzed. Values are log transformed. R = −0.46, p = 0.24.</p

    Proliferation response of PHA and anti-CD3/anti-CD28 stimulated PBMC treated with As<sup>+3</sup>.

    No full text
    <p>Comparison of PHA stimulated (A) and anti-CD3/anti-CD28 stimulated (B) T cell proliferation (<sup>3</sup>H-thymidine) for potential As<sup>+3</sup> inhibition in 17 donors. Data shown are the Mean (red line) and Median (black line) ± SD with *p<.05.</p

    30 Day Arsenic Drinking Water Exposure and Effects on Mouse Body Weight, Spleen Weight, Bone marrow Cell and Spleen Cell recovery<sup>1</sup>

    No full text
    <p>30 Day Arsenic Drinking Water Exposure and Effects on Mouse Body Weight, Spleen Weight, Bone marrow Cell and Spleen Cell recovery<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0093920#nt101" target="_blank">1</a></sup></p

    <i>In vitro</i> (18 hrs) As<sup>+3</sup>, As<sup>+5</sup> or MMA<sup>+3</sup> Exposure and Effects on Mouse Bone marrow Cell Viability<sup>1</sup>

    No full text
    <p><i>In vitro</i> (18 hrs) As<sup>+3</sup>, As<sup>+5</sup> or MMA<sup>+3</sup> Exposure and Effects on Mouse Bone marrow Cell Viability<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0093920#nt102" target="_blank">1</a></sup></p

    Number of colonies per million cells exposed to As<sup>+5</sup> <i>in vitro</i>.

    No full text
    <p>Number of CFU-B colonies per million cells 10 days post plating in mouse methylcellulose media (containing As<sup>+5</sup>) for pre-B cells [Top]. Number of CFU-GM colonies per million cells 14 days post plating in mouse methylcellulose media (containing As<sup>+5</sup>) for GM cells [Bottom]. No significant differences between treatments and control (p<0.05) were found. Results are Means <u>+</u> SD.</p

    Number of colonies per million cells exposed to MMA<sup>+3</sup> <i>in vitro</i>.

    No full text
    <p>Number of CFU-B colonies per million cells 10 days post plating in mouse methylcellulose media (containing MMA<sup>+3</sup>) for pre-B cells [Top]. Number of CFU-GM colonies per million cells 14 days post plating in mouse methylcellulose media (containing MMA<sup>+3</sup>) for GM cells [Bottom]. *Significantly different compared to control (p<0.05). Results are Means <u>+</u> SD.</p
    corecore